All Relations between Multiple Sclerosis and mtor

Publication Sentence Publish Date Extraction Date Species
Daniela Buonvicino, Sara Pratesi, Giuseppe Ranieri, Alessandra Pistolesi, Daniele Guasti, Alberto Chiarug. The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis. Neurobiology of disease. 2023-12-24. PMID:38142841. the mitochondriogenic but not the immunosuppressant effects of mtor inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis. 2023-12-24 2023-12-27 mouse
Swesha Chhabra, Sidharth Mehan, Zuber Khan, Ghanshyam Das Gupta, Acharan S Narul. Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations. Journal of neuroimmunology. vol 384. 2023-09-29. PMID:37774554. matrine's interaction with the stat-3, mtor, and ppar-gamma pathways in multiple sclerosis was also validated and confirmed through insilico investigation. 2023-09-29 2023-10-07 Not clear
Swesha Chhabra, Sidharth Mehan, Zuber Khan, Ghanshyam Das Gupta, Acharan S Narul. Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations. Journal of neuroimmunology. vol 384. 2023-09-29. PMID:37774554. modulating the stat-3, mtor, and ppar-gamma signaling pathways may offer therapeutic potential for multiple sclerosis. 2023-09-29 2023-10-07 Not clear
Yao-Chen Zhang, Ke-Yi Fan, Qi Wang, Jing-Xi Hu, Qian Wang, He-Yi Zhang, Shan Song, Rong Zhao, Jun Qiao, Sheng-Xiao Zhan. Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis. Neurology and therapy. 2023-03-04. PMID:36870011. results from observational studies indicate an association between circulating levels of mammalian target of rapamycin (mtor)-dependent circulating proteins and the risk of multiple sclerosis (ms). 2023-03-04 2023-08-14 Not clear
Yang Yang, Wei Song, Ning Wang, Yuqing Ren, Hongzhuo Li. Tip-concentrated microneedle patch delivering everolimus for therapy of multiple sclerosis. Biomaterials advances. vol 135. 2022-08-05. PMID:35929200. everolimus, as a new generation of mtor inhibitors, can effectively alleviate the inflammatory reaction of the central nervous system and offers a promising choice for the treatment of multiple sclerosis. 2022-08-05 2023-08-14 Not clear
Aigli G Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, Maria Anagnostouli, Leonidas Stefanis, Panos Stathopoulo. The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International journal of molecular sciences. vol 23. issue 15. 2022-07-28. PMID:35897651. importantly, the study of mtor pathway contributions to autoimmune inflammatory demyelination and multiple sclerosis illustrates the difficulties in the clinical application of animal model results. 2022-07-28 2023-08-14 human
Aigli G Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, Maria Anagnostouli, Leonidas Stefanis, Panos Stathopoulo. The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International journal of molecular sciences. vol 23. issue 15. 2022-07-28. PMID:35897651. the mtor signaling pathway in multiple sclerosis; from animal models to human data. 2022-07-28 2023-08-14 human
Aigli G Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, Maria Anagnostouli, Leonidas Stefanis, Panos Stathopoulo. The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International journal of molecular sciences. vol 23. issue 15. 2022-07-28. PMID:35897651. this article recapitulates the evidence on the role of mammalian targets of rapamycin (mtor) complex pathways in multiple sclerosis (ms). 2022-07-28 2023-08-14 human
Kenneth Maies. Novel Insights for Multiple Sclerosis and Demyelinating Disorders with Apoptosis, Autophagy, FoxO, and mTOR. Current neurovascular research. vol 18. issue 2. 2021-11-08. PMID:33964865. novel insights for multiple sclerosis and demyelinating disorders with apoptosis, autophagy, foxo, and mtor. 2021-11-08 2023-08-13 Not clear
Fahimeh Akbarian, Mohammad Amin Tabatabaiefar, Vahid Shaygannejad, Mohammad Mahdi Shahpouri, Negin Badihian, Roshanak Sajjadi, Arezou Dabiri, Nazanin Jalilian, Mohammad Reza Noori-Daloi. Upregulation of MTOR, RPS6KB1, and EIF4EBP1 in the whole blood samples of Iranian patients with multiple sclerosis compared to healthy controls. Metabolic brain disease. vol 35. issue 8. 2021-09-02. PMID:32809098. upregulation of mtor, rps6kb1, and eif4ebp1 in the whole blood samples of iranian patients with multiple sclerosis compared to healthy controls. 2021-09-02 2023-08-13 Not clear
Cinzia Dello Russo, Lucia Lisi, Douglas L Feinstein, Pierluigi Navarr. mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia. vol 61. issue 3. 2013-07-03. PMID:23044764. mtor kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. 2013-07-03 2023-08-12 Not clear